Skip to content
healthcare.dev

Xylocaine

NDC 63323-484, LIDOCAINE HYDROCHLORIDE, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-484
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INFILTRATION, PERINEURAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA006488
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-484 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIDOCAINE HYDROCHLORIDE ANHYDROUS5 mg/mL

Pharmacologic classes

Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Local Anesthesia [PE]

Package NDCNDC-11Package
63323-484-576332304845725 VIAL, MULTI-DOSE in 1 TRAY (63323-484-57) / 50 mL in 1 VIAL, MULTI-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ba082c2f-64f4-419d-9c88-74f203316e17

Use it

Look up 63323-484 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-484 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-484. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.